Skip to main content
. 2019 Feb 26;11(3):275. doi: 10.3390/cancers11030275

Figure 2.

Figure 2

ALK targeting at two fronts. Targeting ALK tyrosine kinase domain with a specific inhibitor can decrease tumor cell proliferation and induce apoptosis. On the other hand, ALK-derived peptides mimicking the ADD domain of ALK were found to be proapoptotic. A combination treatment can bring additive or synergistic efficiency to kill ALK-dependent tumors.